NCT06107010View on ClinicalTrials.gov

Effects of Atalante Exoskeleton on Gait Recovery in Non- or Poorly Ambulatory Patients With Hemiparesis in the Acute/Subacute Phase (Month 1 to 4)

NARecruitingINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

June 12, 2023

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Stroke, AcuteStroke, IschemicStroke, SubacuteStroke HemorrhagicCerebrovascular DisordersCerebrovascular AccidentHemiparesisHemiparesis;Poststroke/CVAHemiparesis/Hemiplegia (One Sided Weakness/Paralysis)
Interventions
DEVICE

Use of the Atalante exoskeleton

Six weeks of exoskeleton sessions replacing conventional therapy sessions three times a week

Trial Locations (5)

Unknown

RECRUITING

Hôpitaux Universitaires Henri Mondor APHP, site Albert Chenevier, Créteil

RECRUITING

Centre de Médecine Physique et de Réadaptation APAJH de Pionsat, Pionsat

NOT_YET_RECRUITING

Schön Klinik, Bad Aibling

RECRUITING

Vivantes Klinikum Spandau, Berlin

RECRUITING

Institut Guttmann, Barcelona

All Listed Sponsors
lead

Wandercraft

INDUSTRY